The innovative drug sector adjusted at the beginning of the trading session, with Aosaikang hitting the limit down, followed by declines in Cosunter, Jimin Health, Huili Pharmaceutical-W, Saili Medical, Rongchang Bio, Wanbangde, and others
The innovative drug sector adjusted at the beginning of the trading session, with Aosaikang hitting the limit down, followed by declines in Cosunter, Jimin Health, Huili Pharmaceutical-W, Saili Medical, Rongchang Biologics, Wanbangde, and others